Direct-To-Consumer (DTC) Genetic Testing Market to Grow with a CAGR of 8.45% Globally through 2029

Ongoing development of genome sequencing technology and rising public awareness regarding direct-to-consumer (DTC) genetic tests are driving demand for direct-to-consumer (DTC) genetic testing during the forecast period of 2025-2029.

According to TechSci Research report, “Direct-To-Consumer (DTC) Genetic Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029F”, the Global Direct-To-Consumer (DTC) Genetic Testing Market stood at USD 1.50 billion in 2023 and is anticipated to grow at a CAGR of 8.45% in the forecast period, 2024-2029. Increasing disposable income and healthcare expenditure combined with rising adoption of customized medicine to treat genetic disease are creating the demand for direct-to-consumer (DTC) genetic testing. Growing awareness among Europeans and Americans regarding racial testing, new technological advances and rising prevalence of many genetic disorders such as diabetes, cancer, cystic fibrosis, and Alzheimer`s disease globally are the other main factors propelling the growth of the direct-to-consumer (DTC) genetic testing market.

Over recent period, it has been observed that Alzheimer's disease impacts an estimated 6.2 million Americans aged 65 and older. Without advancements in medical treatment to prevent, slow, or cure Alzheimer's disease, this number is projected to increase to 13.8 million by 2060. As developed countries improve their ability to manage infectious and nutritional diseases, it has become evident that genetic disorders play a significant role in disability and mortality. Roughly half of the 3% to 6% of newborns born with a recognized birth defect have a primarily genetic origin. Genetic abnormalities are the primary known cause of pregnancy loss in developed nations, with chromosomal abnormalities responsible for nearly half of all spontaneous abortions. In developed countries, genetic disorders contribute to approximately 30% of postnatal infant mortality, as well as 30% of pediatric and 10% of adult hospital admissions. Medical researchers now estimate that genetic defects, regardless of their severity, affect at least 10% of all adults. While tissue biopsy remains the cornerstone for cancer detection, it faces numerous challenges due to its invasive nature, cost, time requirements, and difficulties in sampling tissue heterogeneity prospectively. Direct-to-Consumer (DTC) Genetic Testing has emerged as a non-invasive alternative to overcome these challenges. This method offers a simple, rapid, and valuable approach by analyzing circulating tumor DNA, circulating tumor cells, and other tumor-derived components present in blood plasma.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Direct-To-Consumer (DTC) Genetic Testing Market"

The Global Direct-To-Consumer (DTC) Genetic Testing Market can be segmented into test type, technology, sample, distribution channel, region and by company.

Based on sample, saliva emerged as dominating segment in Global Direct-To-Consumer (DTC) Genetic Testing Market in 2023. Saliva-based testing offers a distinct advantage in terms of cost-effectiveness when compared to alternative sample collection methods, such as blood draws or tissue biopsies. The lower cost associated with saliva-based testing significantly reduces the financial barrier to entry for consumers, making genetic testing accessible to a wider demographic. This affordability not only increases adoption rates but also fuels market expansion by attracting individuals who may have previously been deterred by the higher costs of traditional testing methods. The broader accessibility afforded by saliva-based testing contributes to the democratization of genetic testing, ultimately driving sustained growth within the market.

Based on region, Asia Pacific is growing with the significant pace in Global Direct-To-Consumer (DTC) Genetic Testing Market. 

Numerous international companies providing direct-to-consumer (DTC) genetic testing services are strategically expanding their operations in the Asia Pacific region to capitalize on the escalating market demand. This strategic expansion entails forging partnerships with local healthcare providers to enhance service accessibility and credibility. These companies are actively engaging in targeted marketing campaigns to augment awareness regarding the benefits and significance of genetic testing among diverse demographics. Recognizing the cultural and linguistic diversity prevalent in the region, these companies are customizing their services to resonate with the preferences and sensitivities of local populations. Through these concerted efforts, international players are not only broadening their market reach but also fostering trust and acceptance within the Asia Pacific consumer base, thus catalyzing the growth trajectory of the DTC genetic testing sector in the region.

The leading companies operating in the Global Direct-To-Consumer (DTC) Genetic Testing Market Players are:

• 23andMe, Inc.
• Ancestry.com, LLC
• Color Health, Inc.
• Helix, Inc.
• Counsyl, Inc. 
• My Heritage Ltd. 
• Living DNA Ltd. 
• Mapmygenome India Limited
• Full Genomes Corporation, Inc.
• Direct Laboratory Services, LLC

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Over the past decade, ongoing genetic discoveries and technological advancements have notably expanded the accessibility of genetic testing for various health conditions. This progress in genetic science has given rise to two notable trends such as the direct marketing of genetic tests to consumers through paid advertisements across print media, television, and the internet, and the direct availability of these tests to consumers via online platforms. In the latter trend, consumers now have the option to directly purchase genetic tests that provide insights into personal health risks, ranging from relatively minor traits to significant conditions such as breast cancer and Alzheimer's disease, all without the involvement of their healthcare provider.,”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Direct-To-Consumer (DTC) Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Ancestry & Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier Testing, Skincare Testing, Others), By Technology (Single Nucleotide Polymorphism (SP) chips, Targeted Analysis, Whole Genome Sequencing (WGS), Others), By Sample (Saliva, Urine, Blood, Others), By Distribution Channel (Online and Offline), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Direct-To-Consumer (DTC) Genetic Testing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Direct-To-Consumer (DTC) Genetic Testing Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com